Literature DB >> 22711563

Trichostatin A enhances glutamate transporter GLT-1 mRNA levels in C6 glioma cells via neurosteroid-mediated cell differentiation.

Mari Itoh1, Takara Hiroi, Naoyoshi Nishibori, Takefumi Sagara, Song Her, Mi-Sook Lee, Kyoji Morita.   

Abstract

The neurotoxic effects of excitatory amino acids (EAAs) are suggested to be connected with the chronic loss of neuronal cells, thereby being responsible for the age-related neurodegenerative diseases. Therefore, it seems conceivable that the excitatory amino acid transporters may contribute to the protection of neuronal cells against the excitotoxic damage by facilitating the removal of EAAs from the brain tissue. On the other hand, previous studies have suggested that glial cell differentiation may be involved in the protection and recovery of neural function probably through the elevation of BDNF gene expression in the brain. Based on these findings, histone deacetylase (HDAC) inhibitors are assumed to induce glutamate transporter-1 (GLT-1) gene expression probably through the promotion of glial cell differentiation. Then, we examined the effects of HDAC inhibitors on GLT-1 mRNA levels in rat C6 glioma cells and found that trichostatin A can induce GLT-1 gene transcription following steroid 5α-reductase and GFAP gene expression. Therefore, it seems conceivable that glial cell differentiation may play a potential role in the removal of EAAs probably through the expression of GLT-1, thereby being involved in the protection of neuronal cells against the chronic excitotoxic insults in the brain.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22711563     DOI: 10.1007/s12031-012-9842-1

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  33 in total

1.  Progesterone facilitates the acquisition of avoidance learning and protects against subcortical neuronal death following prefrontal cortex ablation in the rat.

Authors:  E T Asbury; M E Fritts; J E Horton; W L Isaac
Journal:  Behav Brain Res       Date:  1998-12       Impact factor: 3.332

2.  The expression of a small fraction of cellular genes is changed in response to histone hyperacetylation.

Authors:  C Van Lint; S Emiliani; E Verdin
Journal:  Gene Expr       Date:  1996

Review 3.  Selective neuronal degeneration in Huntington's disease.

Authors:  Catherine M Cowan; Lynn A Raymond
Journal:  Curr Top Dev Biol       Date:  2006       Impact factor: 4.897

Review 4.  Histone deacetylase inhibitor activates the p21/WAF1/Cip1 gene promoter through the Sp1 sites.

Authors:  Y Sowa; T Orita; S Hiranabe-Minamikawa; K Nakano; T Mizuno; H Nomura; T Sakai
Journal:  Ann N Y Acad Sci       Date:  1999       Impact factor: 5.691

5.  High-affinity glutamate transporters in the rat retina: a major role of the glial glutamate transporter GLAST-1 in transmitter clearance.

Authors:  T Rauen; W R Taylor; K Kuhlbrodt; M Wiessner
Journal:  Cell Tissue Res       Date:  1998-01       Impact factor: 5.249

6.  Progesterone pretreatment enhances serotonin-stimulated BDNF gene expression in rat c6 glioma cells through production of 5alpha-reduced neurosteroids.

Authors:  Kyoji Morita; Song Her
Journal:  J Mol Neurosci       Date:  2008-01-25       Impact factor: 3.444

7.  Divergent impact of progesterone and medroxyprogesterone acetate (Provera) on nuclear mitogen-activated protein kinase signaling.

Authors:  Jon Nilsen; Roberta Diaz Brinton
Journal:  Proc Natl Acad Sci U S A       Date:  2003-08-18       Impact factor: 11.205

Review 8.  Excitotoxicity and new antiglutamatergic strategies in Parkinson's disease and Alzheimer's disease.

Authors:  Eleni Koutsilieri; Peter Riederer
Journal:  Parkinsonism Relat Disord       Date:  2007       Impact factor: 4.891

Review 9.  Targeted histone deacetylase inhibition for cancer therapy.

Authors:  D M Vigushin; R C Coombes
Journal:  Curr Cancer Drug Targets       Date:  2004-03       Impact factor: 3.428

10.  Trichostatin A stimulates steroid 5alpha-reductase gene expression in rat C6 glioma cells via a mechanism involving Sp1 and Sp3 transcription factors.

Authors:  Song Her; Mi-Sook Lee; Kyoji Morita
Journal:  J Mol Neurosci       Date:  2009-09-02       Impact factor: 3.444

View more
  5 in total

Review 1.  Transglutaminase is a therapeutic target for oxidative stress, excitotoxicity and stroke: a new epigenetic kid on the CNS block.

Authors:  Manuela Basso; Rajiv R Ratan
Journal:  J Cereb Blood Flow Metab       Date:  2013-04-10       Impact factor: 6.200

Review 2.  Genetic dys-regulation of astrocytic glutamate transporter EAAT2 and its implications in neurological disorders and manganese toxicity.

Authors:  Pratap Karki; Keisha Smith; James Johnson; Michael Aschner; Eunsook Y Lee
Journal:  Neurochem Res       Date:  2014-07-27       Impact factor: 3.996

3.  Yin Yang 1 is a repressor of glutamate transporter EAAT2, and it mediates manganese-induced decrease of EAAT2 expression in astrocytes.

Authors:  Pratap Karki; Anton Webb; Keisha Smith; James Johnson; Kyuwon Lee; Deok-Soo Son; Michael Aschner; Eunsook Lee
Journal:  Mol Cell Biol       Date:  2014-01-27       Impact factor: 4.272

4.  Valproic acid attenuates manganese-induced reduction in expression of GLT-1 and GLAST with concomitant changes in murine dopaminergic neurotoxicity.

Authors:  James Johnson; Edward Pajarillo; Pratap Karki; Judong Kim; Deok-Soo Son; Michael Aschner; Eunsook Lee
Journal:  Neurotoxicology       Date:  2018-05-18       Impact factor: 4.294

5.  Astrocytic histone deacetylase 2 facilitates delayed depression and memory impairment after subarachnoid hemorrhage by negatively regulating glutamate transporter-1.

Authors:  Kai Tao; Qing Cai; Xudong Zhang; Lin Zhu; Zhenru Liu; Fei Li; Qiang Wang; Lei Liu; Dayun Feng
Journal:  Ann Transl Med       Date:  2020-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.